SOLSINT 13 MICROGRAMOS SOLUCION ORAL EN ENVASE UNIDOSIS

Ibsa Farmaceutici Italia S.R.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: f8f2bdb1c9a0245b
Drug Cima Aemps Name: SOLSINT 13 MICROGRAMOS SOLUCION ORAL EN ENVASE UNIDOSIS
Register Number: 85613
Holder Company Name: Ibsa Farmaceutici Italia S.R.L.
Marketing Company Name: Instituto Bioquimico Iberico Ibsa S.L.
Authorization Date: 2021-02-16
Dosage Form: SOLUCIÓN ORAL EN ENVASE UNIDOSIS
Dose: 13 microgramos
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized: Yes
Company Name: Ibsa Farmaceutici Italia S.R.L.

LEVOTIROXINA SODICA

0,013 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 16, 2021

Approval ID

f8f2bdb1c9a0245b

Type

Standard